河北医科大学学报
河北醫科大學學報
하북의과대학학보
JOURNAL OF HEBEI MEDICAL UNIVERSITY
2015年
1期
30-33
,共4页
声带息肉%慢性扁桃体炎%临床路径%效果评价
聲帶息肉%慢性扁桃體炎%臨床路徑%效果評價
성대식육%만성편도체염%림상로경%효과평개
vocal cord polyp%chronic tonsillitis%clinical pathway%evaluation
目的:观察临床路径管理在耳鼻喉专科声带息肉和慢性扁桃体炎治疗中应用效果,为耳鼻喉专科单病种的标准化、规范化、同质化治疗提供依据。方法采用回顾性队列研究设计,选择临床路径实施前入院的声带息肉和慢性扁桃体炎患者为对照组,实施临床路径的患者为临床路径组;分析2组患者的住院费用、住院时间、诊疗质量等指标。结果临床路径组与对照组患者基本情况差异均无统计学意义(P>0.05),具有可比性。临床路径组声带息肉患者平均住院总费用、检查费、手术费、药费、其他费用和平均住院时间均少于对照组(P<0.01);临床路径组慢性扁桃体炎患者的平均住院总费用、检查费、手术费、药费、治疗护理费、其他费用和平均住院时间均少于对照组(P<0.01)。声带息肉患者的临床疗效在临床路径组与对照组之间差异无统计学意义(P>0.05);慢性扁桃体炎患者临床疗效临床路径组高于对照组(P<0.05),而住院并发症发生率差异无统计学意义(P>0.05)。结论临床路径管理可以缩短平均住院时间、降低住院费用、提高诊疗质量,有助于耳鼻喉科疾病的规范化、标准化、同质化治疗。
目的:觀察臨床路徑管理在耳鼻喉專科聲帶息肉和慢性扁桃體炎治療中應用效果,為耳鼻喉專科單病種的標準化、規範化、同質化治療提供依據。方法採用迴顧性隊列研究設計,選擇臨床路徑實施前入院的聲帶息肉和慢性扁桃體炎患者為對照組,實施臨床路徑的患者為臨床路徑組;分析2組患者的住院費用、住院時間、診療質量等指標。結果臨床路徑組與對照組患者基本情況差異均無統計學意義(P>0.05),具有可比性。臨床路徑組聲帶息肉患者平均住院總費用、檢查費、手術費、藥費、其他費用和平均住院時間均少于對照組(P<0.01);臨床路徑組慢性扁桃體炎患者的平均住院總費用、檢查費、手術費、藥費、治療護理費、其他費用和平均住院時間均少于對照組(P<0.01)。聲帶息肉患者的臨床療效在臨床路徑組與對照組之間差異無統計學意義(P>0.05);慢性扁桃體炎患者臨床療效臨床路徑組高于對照組(P<0.05),而住院併髮癥髮生率差異無統計學意義(P>0.05)。結論臨床路徑管理可以縮短平均住院時間、降低住院費用、提高診療質量,有助于耳鼻喉科疾病的規範化、標準化、同質化治療。
목적:관찰림상로경관리재이비후전과성대식육화만성편도체염치료중응용효과,위이비후전과단병충적표준화、규범화、동질화치료제공의거。방법채용회고성대렬연구설계,선택림상로경실시전입원적성대식육화만성편도체염환자위대조조,실시림상로경적환자위림상로경조;분석2조환자적주원비용、주원시간、진료질량등지표。결과림상로경조여대조조환자기본정황차이균무통계학의의(P>0.05),구유가비성。림상로경조성대식육환자평균주원총비용、검사비、수술비、약비、기타비용화평균주원시간균소우대조조(P<0.01);림상로경조만성편도체염환자적평균주원총비용、검사비、수술비、약비、치료호리비、기타비용화평균주원시간균소우대조조(P<0.01)。성대식육환자적림상료효재림상로경조여대조조지간차이무통계학의의(P>0.05);만성편도체염환자림상료효림상로경조고우대조조(P<0.05),이주원병발증발생솔차이무통계학의의(P>0.05)。결론림상로경관리가이축단평균주원시간、강저주원비용、제고진료질량,유조우이비후과질병적규범화、표준화、동질화치료。
Objective To explore the effect of the clinical path management in treatment of vocal cord polyp and chronic tonsillitis,to provide the scientific advice for the standardization, regulation and homogeneity of the ear-nose-throat (ENT)single disease treatment.Methods A retrospective cohort study from Suining Center Hospital was applied to compare the status between traditional group and the clinical pathway group.The main evaluation indicators included hospital cost,hospitalization day and treatment effects.Results The differences of basic situation such as vocal cord polyp and chronic tonsillitis between the clinical pathway group and the control group were not significant (P>0.05).The average total cost of hospitalization,inspection fee, surgery fee,drugs fee,other treatment charge and the average hospitalization day of the vocal cord polyp clinical pathway group were less than those of the control group (P<0.05);the average total cost of hospitalization,inspection fee,surgery fee,drugs fee,nursing fee,other treatment charge and the average hospitalization day of the chronic tonsillitis clinical pathway group were less than those of the control group (P<0.01);Clinical curative effect between the vocal cord polyp clinical pathway group and the control group were not significant (P>0.05 );Clinical curative effect of chronic tonsillitis patients path group was higher (P<0.05 ),whereas the incidence of hospital complications,infection,between the path and control group were no significant (P>0.05).Conclusion Clinical path management can shorten the average length of hospitalization,reduce the hospital cost and improve the quality of diagnosis and treatment to help standardize the treatment of ENT diseases.